Comparison of the DCE pharmacokinetic parameters of patients with true progression versus pseudoprogression
Pharmacokinetic Parameter | T1 Method | True Progression (n = 15) | Pseudoprogression (n = 22) | P Valuea | Intraclass Correlation Coefficient [95% CI] | |||
---|---|---|---|---|---|---|---|---|
Mean ± SD | Median [range] | Mean ± SD | Median [range] | Intraobserver | Interobserver | |||
Ktrans, min−1 | Fixed | 0.138 ± 0.148 | 0.096 [0.042–0.579] | 0.068 ± 0.043 | 0.064 [0.0005–0.154] | .05b | 0.893 [0.792–0.945] | 0.897 [0.799–0.947] |
Measured | 0.126 ± 0.139 | 0.069 [0.025–0.499] | 0.056 ± 0.045 | 0.058 [0.0001–0.194] | .10 | 0.923 [0.850–0.960] | 0.943 [0.888–0.970] | |
Kep, min−1 | Fixed | 0.321 ± 0.244 | 0.244 [0.135–1.082] | 0.179 ± 0.103 | 0.179 [0.024–0.483] | .01b | 0.910 [0.825–0.954] | 0.929 [0.862–0.963] |
Measured | 0.224 ± 0.108 | 0.202 [0.035–0.396] | 0.192 ± 0.148 | 0.157 [0.009–0.494] | .47 | 0.861 [0.729–0.928] | 0.882 [0.771–0.939] | |
Vp, % | Fixed | 3.309 ± 4.429 | 1.468 [0.709–18.298] | 1.998 ± 1.462 | 1.705 [0.140–6.723] | .60 | 0.872 [0.752–0.934] | 0.888 [0.784–0.943] |
Measured | 2.358 ± 2.701 | 1.339 [0.478–10.407] | 1.521 ± 1.456 | 1.134 [0.081–6.056] | .27 | 0.800 [0.605–0.895] | 0.688 [0.394–0.839] | |
Ve | Fixed | 0.536 ± 0.330 | 0.446 [0.168–1.050] | 0.506 ± 0.284 | 0.482 [0.114–1.156] | .77 | 0.761 [0.537–0.877] | 0.718 [0.516–0.844] |
Measured | 0.550 ± 0.511 | 0.377 [0.121–1.192] | 0.316 ± 0.265 | 0.270 [0.041–1.297] | .08 | 0.937 [0.877–0.968] | 0.936 [0.875–0.967] |